https://www.selleckchem.com/pr....oducts/trastuzumab-e
5%) and intensive care unit (ICU) admission (10.4%). The overall healthcare expenditure in treating DFU is high, with hospital admissions and surgical procedures adding a significant increase to the total cost. Focused patient education on overall glycemic control and prevention of DFU may decrease complications and hence, the overall cost. Identified only the direct medical costs of DFU as the indirect costs were subjective and more difficult to quantify. None. None.Adverse cutaneous reactions are rarely seen with